Brad Marder
Overview
Explore the profile of Brad Marder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albert J, Broadwell A, Padnick-Silver L, Marder B, LaMoreaux B
Medicine (Baltimore)
. 2024 Mar;
103(10):e37424.
PMID: 38457582
Chronic kidney disease (CKD) and gout commonly co-occur. Pegloticase lowers serum urate (SU) in uncontrolled gout patients but antidrug antibodies limit urate-lowering response and increase infusion reaction (IR) risk. Methotrexate...
2.
Alex R, Press E, Sanchez L, Whitson J, Marder B, Tumlin J
J Clin Rheumatol
. 2024 Feb;
PMID: 38351500
Background: The association between hyperuricemia and development of progressive chronic kidney disease has received increasing attention in recent years. Recent preclinical studies have shown that non-crystalline uric acid can induce...
3.
Guedes M, Zhao J, LaMoreaux B, Marder B, Gorlitsky B, Domingues V, et al.
Kidney360
. 2023 Jan;
4(1):54-62.
PMID: 36700904
Introduction: Gout occurs frequently in patients with kidney disease and can lead to a significant burden on quality of life. Gout prevalence, and its association with outcomes in hemodialysis (HD)...
4.
Trachtman H, Nelson P, Adler S, Campbell K, Chaudhuri A, Derebail V, et al.
J Am Soc Nephrol
. 2018 Oct;
29(11):2745-2754.
PMID: 30361325
Background: We evaluated and compared the effects of sparsentan, a dual endothelin type A (ET) and angiotensin II type 1 receptor antagonist, with those of the angiotensin II type 1...
5.
Marder B, Schroppel B, Murphy B
Curr Opin Urol
. 2003 Feb;
13(2):81-9.
PMID: 12584466
Purpose Of Review: The purpose of this review is to summarize recent advances within the area of genetic polymorphisms with a specific emphasis on renal transplantation, and to discuss the...
6.
Schroppel B, Fischereder M, Lin M, Marder B, Schiano T, Kramer B, et al.
J Clin Immunol
. 2002 Dec;
22(6):381-5.
PMID: 12462338
Chemokines and their receptors play a major role in the inflammatory and immune responses that mediate allograft outcome. The production of some chemokines varies among individuals and these variations may...
7.
Kruger B, Schroppel B, Ashkan R, Marder B, Zulke C, Murphy B, et al.
J Am Soc Nephrol
. 2002 Sep;
13(10):2585-9.
PMID: 12239249
Among the factors modulating transplant rejection and cardiovascular disease, chemokines and their respective receptors deserve special attention. In this respect, increased expression of MCP-1 and the corresponding receptor CCR2 have...